CorConsult Rx - #Repost from @rxkeyslides who always posts fantastic content! ・・・ DOAC Refresher: Dosing Recommendations for DVT/PE Treatment 💊🤓 ~ And some key pearls: 1. VTE treatment duration: optimal duration of
![Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/ddi/2020/apixaban-direct-factor-xa-inhibitor-1024x576.jpg)
Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation
![Anticoagulation in Acute Pulmonary Embolism: Which Drug? How Long? - Kardiologie & Gefäßmedizin - Universimed - Medizin im Fokus Anticoagulation in Acute Pulmonary Embolism: Which Drug? How Long? - Kardiologie & Gefäßmedizin - Universimed - Medizin im Fokus](https://www.universimed.com/__image/a/286905/alias/xxl/v/2/c/10/ar/flexible/fn/Fig%201.jpg)
Anticoagulation in Acute Pulmonary Embolism: Which Drug? How Long? - Kardiologie & Gefäßmedizin - Universimed - Medizin im Fokus
![Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction | Cardiology and Therapy Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction | Cardiology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40119-022-00254-w/MediaObjects/40119_2022_254_Fig2_HTML.png)
Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction | Cardiology and Therapy
![Life | Free Full-Text | Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism Life | Free Full-Text | Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism](https://www.mdpi.com/life/life-12-00705/article_deploy/html/images/life-12-00705-g001.png)